# C4 Therapeutics, Inc.: Form 8-K, filed May 12, 2026

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2026-05-12
- Accepted by EDGAR: May 12, 2026, 11:05 ET
- Period: 2026-05-12
- Accession: 0001628280-26-033861
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000162828026033861/cccc-20260512.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000162828026033861/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000162828026033861/cccc-20260512.htm

Filed May 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-033861. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.